Citation Tools
PDFEditorial
Challenge to levetiracetam’s de facto position as generic first-line antiseizure medication
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Challenge to levetiracetam’s de facto position as generic first-line antiseizure medication
Other content recommended for you
- NICE guideline review: Epilepsies in children, young people and adults NG217
- Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial
- Intravenous brivaracetam for the management of refractory focal non-convulsive status epilepticus
- Epilepsy and pregnancy: identifying risks
- Drug treatment of epilepsy in adults
- Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010–2015)
- The new antiepileptic drugs
- Diagnosis and management of the epilepsies in children: a summary of the partial update of the 2012 NICE epilepsy guideline
- Multicentre observational status-epilepticus registry: protocol for ICTAL
- Should we accept the status quo? Time for new trials in status epilepticus